Enrico N. De Toni

Sitert av

	Alle	Siden 2019
Sitater	6096	4512
h-indeks	36	27
i10-indeks	88	80

1500

750

375

1125

20072008200920102011201220132014201520162017201820192020202120222023202423 42 74 102 127 142 149 173 165 171 181 188 255 349 505 817 1138 1410

Offentlig tilgang

Vis alle

37 artikler

4 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Florian P. ReiterDivision of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, GermanyVerifisert e-postadresse på ukw.de
Burkhard GokeConsulting ProfessorVerifisert e-postadresse på uke.de
Julia MayerleProfessor and Chair Department of Medicine II, LMU MunichVerifisert e-postadresse på med.uni-muenchen.de
Najib Ben KhaledLMU Munich University Hospital, Department of Medicine IIVerifisert e-postadresse på med.uni-muenchen.de
Eike GallmeierDepartment of Internal Medicine, Klinikum MemmingenVerifisert e-postadresse på klinikum-memmingen.de
Bruno SangroProfessor of Medicine, Universidad de NavarraVerifisert e-postadresse på unav.es
Liangtao YeCenter for Digestive Diseases, The Seventh Affiliated Hospital, Sun Yat-sen UniversityVerifisert e-postadresse på med.uni-muenchen.de
Prof. Dr. med. Markus GubaChirurgische Klinik, Klinikum Großhadern, Universität MünchenVerifisert e-postadresse på med.uni-muenchen.de
Antonio GasbarriniProfessor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, ItalyVerifisert e-postadresse på iol.it
Arndt VogelToronto General Hospital/ Princess Margaret Cancer Center 🇨🇦/Medizinische Hochschule Hannover🇩🇪Verifisert e-postadresse på mh-hannover.de
Stephen L. Chan 陳林醫生教授Professor, Department of Clinical Oncology, The Chinese University of Hong KongVerifisert e-postadresse på cuhk.edu.hk
Hendrik SeeligerCharité Universitätsmedizin BerlinVerifisert e-postadresse på charite.de
Yoon-Koo KangAsan Medical CenterVerifisert e-postadresse på amc.seoul.kr
Pinter MatthiasMedizinische Universität WienVerifisert e-postadresse på meduniwien.ac.at
Andreas JungProfessor for Molecular Pathology, University of MunichVerifisert e-postadresse på lmu.de
Peter GalleProfessor für Medizin, Mainz UniversityVerifisert e-postadresse på uni-Mainz.de
Sören EichhorstVerifisert e-postadresse på artemiskliniken.de
Ivan BorbathFaculté de médecine, Université catholique de LouvainVerifisert e-postadresse på uclouvain.be
Camillo PortaTranslational Oncology, IRCCS Istituti Clinici Scientifici MaugeriVerifisert e-postadresse på icsmaugeri.it
jl van laethemVerifisert e-postadresse på erasme.ulb.ac.be

Følg

Enrico N. De Toni

Professor of Medicine, University of Munich

Verifisert e-postadresse på med.uni-muenchen.de - Startside

Oncology immunotherapy liver cancer gastrointestinal tumors


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma GK Abou-Alfa, G Lau, M Kudo, SL Chan, RK Kelley, J Furuse, ... NEJM evidence 1 (8), EVIDoa2100070, 2022	781	2022
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects W Tang, Z Chen, W Zhang, Y Cheng, B Zhang, F Wu, Q Wang, S Wang, ... Signal transduction and targeted therapy 5 (1), 87, 2020	683	2020
Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma … GK Abou-Alfa, SL Chan, M Kudo, G Lau, RK Kelley, J Furuse, ... Journal of Clinical Oncology 40 (4_suppl), 379-379, 2022	360	2022
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma J Ricke, HJ Klümpen, H Amthauer, I Bargellini, P Bartenstein, EN de Toni, ... Journal of hepatology 71 (6), 1164-1174, 2019	321	2019
The role of the novel Th17 cytokine IL-26 in intestinal inflammation J Dambacher, F Beigel, K Zitzmann, EN De Toni, B Göke, HM Diepolder, ... Gut 58 (9), 1207-1217, 2009	316	2009
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells K Zitzmann, EN De Toni, S Brand, B Göke, J Meinecke, G Spöttl, ... Neuroendocrinology 85 (1), 54-60, 2007	206	2007
Checkpoint Inhibitors: the diagnosis and treatment of side effects L Heinzerling, EN de Toni, G Schett, G Hundorfean, L Zimmer Deutsches Ärzteblatt International 116 (8), 119, 2019	154	2019
EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma H Seeliger, P Camaj, I Ischenko, A Kleespies, EN De Toni, SE Thieme, ... Molecular Cancer Research 7 (2), 189-198, 2009	125	2009
Use of checkpoint inhibitors in liver transplant recipients S Munker, EN De Toni United European gastroenterology journal 6 (7), 970-973, 2018	111	2018
Inhibition of ataxia telangiectasia-and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133+ … E Gallmeier, PC Hermann, MT Mueller, JG Machado, A Ziesch, ... Stem Cells 29 (3), 418-429, 2011	111	2011
Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G₂/M Cell Cycle Arrest C Kuntzen, N Sonuc, EN De Toni, C Opelz, SR Mucha, AL Gerbes, ... Cancer research 65 (15), 6780-6788, 2005	104	2005
OPG is regulated by β-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer EN De Toni, SE Thieme, A Herbst, A Behrens, P Stieber, A Jung, H Blum, ... Clinical cancer research 14 (15), 4713-4718, 2008	101	2008
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells P Camaj, H Seeliger, I Ischenko, S Krebs, H Blum, EN De Toni, ... Walter de Gruyter 390 (12), 1293-1302, 2009	97	2009
Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study EN De Toni, A Schlesinger-Raab, M Fuchs, W Schepp, U Ehmer, ... Gut 69 (1), 168-176, 2020	95	2020
Tapering of immunosuppression and sustained treatment with nivolumab in a liver transplant recipient. EN De Toni, AL Gerbes Gastroenterology 152 (6), 1631-1633, 2017	93	2017
Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling I Ischenko, P Camaj, H Seeliger, A Kleespies, M Guba, EN De Toni, ... Oncogene 27 (57), 7212-7222, 2008	88	2008
Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C P Amodio, EN De Toni, L Cavalletto, D Mapelli, E Bernardinello, ... Journal of affective disorders 84 (1), 93-98, 2005	85	2005
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma–A novel therapeutic approach SM Ehrlich, J Liebl, MA Ardelt, T Lehr, EN De Toni, D Mayr, L Brandl, ... Journal of hepatology 63 (1), 102-113, 2015	82	2015
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand SR Mucha, A Rizzani, AL Gerbes, P Camaj, WE Thasler, CJ Bruns, ... Gut 58 (5), 688-698, 2009	81	2009
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib L Rimassa, G Abbadessa, N Personeni, C Porta, I Borbath, B Daniele, ... Oncotarget 7 (45), 72622, 2016	73	2016

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere